Innova Captab Ltd

Innova Captab Ltd was incorporated as Harun Health Care Private Limited, dated January 3, 2005 at Mumbai. Thereafter, name of the Company changed from Harun Health Care Private Limited to Innova Captab Private Limited, and consequently, a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company converted to a Public Company on July 12, 2018, and consequently, its name was changed to Innova Captab Limited, dated July 26, 2018.The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial largescale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals. In 2006, the first manufacturing plant got established in Baddi, at Himachal Pradesh. In 2010, it commenced operations at the cephalosporin block of their plant in Baddi. In 2021, the Company acquired business of Innova Captab, a Partnership Firm effective as of March 31, 2021 and acquired Univentis Medicare Limited (UML) 100% equity shares effective on December 31, 2021 and consequently, The Univentis Foundation became a Subsidiary of Company on June 14, 2021.The Company is planning to raise capital from Public by raising 400 crore Equity Shares through Fresh Issue and 9,600,000 Equity Shares through Offer for Sale.